GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 88 filers reported holding GENMARK DIAGNOSTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $18,275,000 | +39.5% | 1,493,076 | +34.4% | 0.00% | 0.0% |
Q3 2016 | $13,104,000 | +43.8% | 1,110,548 | +6.0% | 0.00% | +50.0% |
Q2 2016 | $9,114,000 | +58.1% | 1,047,584 | -4.2% | 0.00% | +100.0% |
Q1 2016 | $5,765,000 | -42.7% | 1,093,928 | -15.6% | 0.00% | -50.0% |
Q4 2015 | $10,056,000 | +3.3% | 1,295,900 | +4.8% | 0.00% | -33.3% |
Q3 2015 | $9,734,000 | -18.1% | 1,236,835 | -5.7% | 0.00% | 0.0% |
Q2 2015 | $11,879,000 | -30.9% | 1,311,201 | -0.9% | 0.00% | -25.0% |
Q1 2015 | $17,179,000 | +8.9% | 1,323,517 | +14.1% | 0.00% | 0.0% |
Q4 2014 | $15,781,000 | +74.6% | 1,159,521 | +15.1% | 0.00% | +33.3% |
Q3 2014 | $9,040,000 | -35.4% | 1,007,817 | -2.5% | 0.00% | -25.0% |
Q2 2014 | $13,984,000 | +39.4% | 1,033,525 | +2.4% | 0.00% | +33.3% |
Q1 2014 | $10,030,000 | -22.5% | 1,009,065 | +3.6% | 0.00% | -25.0% |
Q4 2013 | $12,943,000 | +5.1% | 973,906 | -4.0% | 0.00% | 0.0% |
Q3 2013 | $12,319,000 | +62.9% | 1,014,749 | +38.9% | 0.00% | +33.3% |
Q2 2013 | $7,561,000 | – | 730,701 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 3,365,000 | $16,186,000 | 1.49% |
CADIAN CAPITAL MANAGEMENT, LP | 5,517,767 | $26,540,000 | 1.17% |
NEEDHAM INVESTMENT MANAGEMENT LLC | 1,590,000 | $7,646,000 | 1.04% |
Parkman Healthcare Partners LLC | 420,000 | $2,020,000 | 0.58% |
Penn Capital Management Company, LLC | 977,526 | $4,702,000 | 0.49% |
Bullseye Asset Management LLC | 79,272 | $381,000 | 0.37% |
Bellevue Group AG | 2,441,241 | $11,742,000 | 0.19% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 300,783 | $1,447,000 | 0.18% |
Granite Investment Partners, LLC | 589,313 | $2,835,000 | 0.13% |
WRAPMANAGER INC | 68,163 | $328,000 | 0.10% |